Indefinite Delivery Contract 75N92024D00005

Award Date 4/1/24
Last Date to Order 3/31/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded Precision For Medicine, Inc. a single-award Indefinite Delivery Contract with a potential value of $98.7 million to maintain, enhance and expand the NIDDK Biorepository component of the NIDDK Central Repository. Under a $50.8 million firm fixed price delivery order, Precision For Medicine will maintain and enhance the Biorepository's routine operations through May 2033 in Frederick,...
The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract with a potential value of $500 million to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract aims to support the Trans-Omics for Precision Medicine initiative through the provision of genomics data generation, analysis, and management services. Under the contract, the National...
This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Fisher Bioservices Inc.'s Clinical Trials Division. The $100,000,000 contract has an ultimate completion date of January 21, 2035 and was awarded on January 22, 2025. The contract is for the storage, monitoring, distribution, and occasional destruction of human biospecimens collected by NICHD as part of its research on child...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a multiple award indefinite delivery/indefinite quantity contract with a potential value of seventy-five million dollars to provide data repository services supporting its biomedical research programs. No set-aside provisions were used. The prime contractor, Booz Allen Hamilton Inc., received two task orders under the contract to date. One task order valued at three hundred fifty-nine thousand eight hundred ten...
This indefinite delivery contract, awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services, provides for a Centralized Omics Resource (CORE) to support the Trans-Omics for Precision Medicine (TOPMed) initiative. The multiple-award contract has a total ceiling value of $505,000,000 and a period of performance through September 2033. Cedars-Sinai Medical Center, a non-profit academic medical center, was selected as a prime...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a single-award Indefinite Delivery Contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of goods. The contract, valued at a potential $696,028, aims to procure custom antibody development services in support of the agency's biomedical research initiatives. Through associated firm fixed price...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a single-award Indefinite Delivery Contract (IDC) to Illumina, Inc. worth up to $767,216.60 for the procurement of TAS::75 0888::TAS SY-401-1001 HISEQ 2000 products and services. The period of performance is from May 27, 2011 to May 29, 2012. Illumina, a for-profit manufacturer of genetic sequencing and genomic analysis instruments and reagents, has previously received prime...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded an indefinite delivery contract to Information Management Services, Inc. to provide data repository services. The multiple award contract has a potential value of $75 million over a 10-year ordering period ending November 2030. The contract supports two task areas. Task Area A involves operating the day-to-day functions of the NIDDK Central Repository, which coordinates data and...
  • 75N92024D00005
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) awarded a $8,803,200.00 Delivery Order contract to Precision For Medicine, Inc., a for-profit organization, for a Biologic Specimen Repository. The contract is cost-plus-award-fee and runs from April 1, 2024 to March 31, 2029.

Precision For Medicine, Inc. is an experienced provider of biorepository services, having previously supported repositories for the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and NIH. The contract involves receipt, storage, tracking, preparation, and distribution of biological specimens and samples to support medical research initiatives at NHLBI. This Delivery Order is part of a broader Indefinite Delivery Contract (IDC) with a potential total value of $10,117,080.00 and a period of performance from April 1, 2024 to March 31, 2029. No set-aside designations were used for this award.

Generated 4/3/24, 10:15 AM